Author

Ali Afgar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer

Findings underscore curcumin’s dual role as an epigenetic modulator (via miR-29b/DNMT3B/MUC1) and ROS inducer, offering a promising strategy for targeted pancreatic cancer therapy.

Ali Afgar, Saeed Zanganeh, R. Mirzaee Khalilabadi et al. · In Silico Pharmacology · 0 citations